[1]
Sitepu, R., Ascobat, P., Ekasari, F. and Instiaty, I. 2018. FIXED-DOSE COMBINATION VERSUS SEPARATE ANTITUBERCULOSIS FORMULATIONS IN PULMONARY TUBERCULOSIS PATIENTS: EVALUATION OF EFFECTIVENESS AND SAFETY. International Journal of Applied Pharmaceutics. 10, 1 (Dec. 2018), 208–210. DOI:https://doi.org/10.22159/ijap.2018.v10s1.46.